Recurrent plasma cell myeloma Clinical Trials

Delta Trials indexes 77 clinical trials for Recurrent plasma cell myeloma in its publicly accessible dataset. Of these, 5 enrolling participants at this time and 44 trials have reached completion. This research takes place spanning 340 research sites around the world. An additional 28 trials are in preparatory or other active non-recruiting stages. Since 2020, 18 trials were terminated, illustrating the dynamic nature of clinical research. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.